E165 – Inhaled cannabis therapy benefits diabetic care mapping - Dr. Dror Robinson

Dr. Dror Robinson’s five-year longitudinal Israeli study goal was to evaluate inhaled cannabis use for diabetic neuropathy. He found it works and he now believes all diabetics should be inhaling cannabis flower. The study can be faulted for the lack of diversity with the 52 individuals sampled, however the study presents a 97% sample retention, and the evidence suggests every participant benefitted from the in-haled cannabis therapy. In this episode, Kirk and Trevor discuss the real-world application of cannabis medicine found to reduce pain, positively modulates the A1C, and decreases the pharmaceutical costs for people with diabetes. This is a must listen for those who are affected by diabetes.

Dr. Robinson - LinkedIn

Transcripts, papers and so much more at: reefermed.ca